Global consumer health apps downloads topped 1.1 billion in 2023 while global OTC revenue hit $150.8B the same year, underscoring how fast access to care and self management keeps expanding. Yet the data also spotlights the friction points behind that growth, from 68% of consumers relying on internet searches before buying OTC products to quality and labeling concerns that appear in real testing. Below, the biggest consumer health statistics connect affordability, behavior, and compliance into one clear picture of what is changing and what still needs fixing.
Key Takeaways
- OTC availability and affordability are among key drivers in the OTC market, with $255B market revenue in 2023
- Dietary supplement market size of $420.2B in 2023 indicates sustained growth in consumer health categories
- 6.7% of all U.S. adults used a prescription for weight loss or diabetes medication for weight loss in 2023 (NHIS survey share)
- 43% of U.S. adults reported using online information about health conditions (2022 survey)
- 46% of U.S. adults track at least one health metric with a wearable or phone (2021 survey)
- In 2023, 1 in 7 U.S. adults used an OTC medication in the past week (NHIS-derived statistic)
- U.S. dietary supplement consumer spending increased from $8.3B (2010) to $17.1B (2020) in a BLS-derived time series (CEX)
- The average price of OTC allergy medications increased by 3.9% year-over-year in 2023 (U.S. CPI subcomponent)
- U.S. dietary supplement recall rate was about 1.2 recalls per month in 2023 (FDA recall database time series)
- In 2022, FDA recalled 100+ dietary supplements for contamination risks (FDA recall database)
- Global dietary supplement market revenue was $177.4B in 2023 (revenue estimate)
- U.S. over-the-counter (OTC) healthcare product sales totaled about $440B in 2023 (sales estimate)
- Global OTC medicines market size reached $150.8B in 2023 (market estimate)
- Dietary supplement quality issues were detected in 6% of products tested in a randomized sampling study (2021–2022)
- In a 2023 systematic review, 14% of supplements analyzed had inaccurate label claims compared with laboratory testing results (meta-analysis)
With OTC and dietary supplements booming, more Americans use online info and wearables to manage health, fueling sustained growth.
Related reading
01 · Category
Industry Trends12 stats
01
OTC availability and affordability are among key drivers in the OTC market, with $255B market revenue in 2023
02
Dietary supplement market size of $420.2B in 2023 indicates sustained growth in consumer health categories
03
6.7% of all U.S. adults used a prescription for weight loss or diabetes medication for weight loss in 2023 (NHIS survey share)
04
3.1% of U.S. adults used a prescription weight-loss medication in 2021-2022 (NHIS)
05
Telehealth adoption: 23x increase in use from pre-pandemic levels (AHRQ assessment referencing national trends)
06
Global digital health investment reached $21.5B in Q1 2024 (PitchBook/industry tracker summary)
07
Global consumer health funding reached $7.8B in 2023 (PitchBook/industry tracker summary)
08
34% of consumers say they would pay more for products that are transparently sourced (survey evidence)
09
In 2023, 62% of consumers said they check ingredient lists and labels before buying health-related products (survey)
10
Consumers spent $5.4B on functional beverages in the U.S. in 2023 (sales estimate)
11
Wearable sensor shipments increased to 410M units globally in 2023 (shipments estimate)
12
Global consumer health apps downloads exceeded 1.1 billion in 2023 (downloads estimate)
Interpretation
Industry Trends Interpretation
Industry Trends are being driven by rapid digital and consumer behavior shifts, with telehealth use jumping 23 times over pre pandemic levels and consumers increasingly focusing on product transparency and ingredients, as shown by 62% checking labels and 34% willing to pay more for transparently sourced products.
02 · Category
User Adoption6 stats
01
43% of U.S. adults reported using online information about health conditions (2022 survey)
02
46% of U.S. adults track at least one health metric with a wearable or phone (2021 survey)
03
In 2023, 1 in 7 U.S. adults used an OTC medication in the past week (NHIS-derived statistic)
04
68% of consumers report using internet searches to learn about health conditions before purchasing OTC products (survey evidence)
05
In 2023, U.S. adults using a health-related mobile app grew by 6 percentage points vs 2020 (Pew Internet trend dataset)
06
10% of adults in the U.S. reported using dietary supplements in the past 30 days (2017–2018 NHANES, adults age 20+)
Interpretation
User Adoption Interpretation
User adoption is clearly rising as nearly half of U.S. adults, 46%, track health metrics with a wearable or phone and 68% use internet searches to learn about health conditions before buying OTC products, while health-related mobile app use increased by 6 percentage points since 2020.
03 · Category
Cost Analysis2 stats
01
U.S. dietary supplement consumer spending increased from $8.3B (2010) to $17.1B (2020) in a BLS-derived time series (CEX)
02
The average price of OTC allergy medications increased by 3.9% year-over-year in 2023 (U.S. CPI subcomponent)
Interpretation
Cost Analysis Interpretation
From a cost-analysis standpoint, U.S. dietary supplement spending more than doubled from $8.3B in 2010 to $17.1B in 2020 while OTC allergy medication prices rose 3.9% year over year in 2023, signaling sustained upward consumer costs across key consumer health categories.
More related reading
04 · Category
Performance Metrics2 stats
01
U.S. dietary supplement recall rate was about 1.2 recalls per month in 2023 (FDA recall database time series)
02
In 2022, FDA recalled 100+ dietary supplements for contamination risks (FDA recall database)
Interpretation
Performance Metrics Interpretation
Performance metrics show that U.S. dietary supplement recalls were steady at about 1.2 recalls per month in 2023, and in 2022 the FDA issued 100 plus recalls tied to contamination risks, underscoring an ongoing quality challenge in the consumer health sector.
05 · Category
Market Size4 stats
01
Global dietary supplement market revenue was $177.4B in 2023 (revenue estimate)
02
U.S. over-the-counter (OTC) healthcare product sales totaled about $440B in 2023 (sales estimate)
03
Global OTC medicines market size reached $150.8B in 2023 (market estimate)
04
Global skin care market was valued at $196.5B in 2023 (market estimate)
Interpretation
Market Size Interpretation
In the Market Size view, consumer health is clearly expanding across key segments, with 2023 revenue or sales ranging from $150.8B for global OTC medicines to $177.4B for global dietary supplements and $440B in U.S. OTC healthcare products, while skin care also reaches $196.5B.
06 · Category
Regulatory & Quality3 stats
01
Dietary supplement quality issues were detected in 6% of products tested in a randomized sampling study (2021–2022)
02
In a 2023 systematic review, 14% of supplements analyzed had inaccurate label claims compared with laboratory testing results (meta-analysis)
03
In a 2022 laboratory study, 1 in 5 supplements tested failed at least one quality parameter (study estimate)
Interpretation
Regulatory & Quality Interpretation
Regulatory and quality checks show a persistent risk, with around 6% to 20% of dietary supplements failing key standards in testing and 14% of analyzed products having inaccurate label claims compared with laboratory results.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Lukas Bauer. (2026, February 13). Consumer Health Industry Statistics. Gitnux. https://gitnux.org/consumer-health-industry-statistics
MLA
Lukas Bauer. "Consumer Health Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/consumer-health-industry-statistics.
Chicago
Lukas Bauer. 2026. "Consumer Health Industry Statistics." Gitnux. https://gitnux.org/consumer-health-industry-statistics.
Sources & references
29 datasets cited across this report · attribution is report-level
+10 additional datasets cited (not shown individually)